{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2140"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2140","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Doxorubicin Cytotoxicity in a Human Proximal Tubular Epithelial Cell Line was Attenuated by the Natural Product Resveratrol","abstract":"The cancer chemotherapeutic agent doxorubicin (DOX), Adriamycin, is part of the treatment regimen for breast, ovarian, small cell lung cancer and acute/chronic lymphoid leukemia. Adverse effects associated with DOX are cardiotoxicity and nephrotoxicity. Interventions are needed to reduce DOX nephrotoxicity. Resveratrol (RES) is a phytochemical contained in grapes, berries and nuts, which possesses antioxidant and anticancer properties. This study tested the hypothesis that RES will attenuate DOX renal cytotoxicity in human noncancerous renal proximal tubular epithelial (HK-2) cells and that RES will reduce DOX mediated changes in mitochondrial function. HK-2 cells were plated and grown for 48 hours (h). Cells were next preincubated for 1h with 0 (DMSO), 5 or 7.5 µM RES followed by a 24 h co-incubation with 0-5 µM DOX. RES did not alter cell growth or viability at the concentrations tested as indicated by comparable MTT values between DMSO and RES groups (p>0.05). Cell viability was further assessed by cell count using Trypan blue exclusion. DOX produced a concentration dependent decline in viability within a 24 h exposure. Pretreatment for 1 h with RES was sufficient to reduce DOX loss of cell viability. Studies were initiated to investigate the cellular mechanism of RES attenuation of DOX cytotoxicity. Western blot of cells following 24 h exposure examined increased protein carbonylation as an indicator of oxidative stress. Initial studies were begun to examine the DOX effects on mitochondrial oxygen consumption using a Seahorse platform. In summary, RES did not diminish cell viability at the concentrations tested in our HK-2 cells. DOX diminished cell viability within 24 h relative to vehicle control. A 1 h pretreatment with RES reduced DOX cytotoxicity in HK-2 cells. Prevention of mitochondrial impairment and oxidative stress by DOX are potential mechanisms for RES protection in HK-2 cells.","abstract_html":"The cancer chemotherapeutic agent doxorubicin (DOX), Adriamycin, is part of the treatment regimen for breast, ovarian, small cell lung cancer and acute/chronic lymphoid leukemia. Adverse effects associated with DOX are cardiotoxicity and nephrotoxicity. Interventions are needed to reduce DOX nephrotoxicity. Resveratrol (RES) is a phytochemical contained in grapes, berries and nuts, which possesses antioxidant and anticancer properties. This study tested the hypothesis that RES will attenuate DOX renal cytotoxicity in human noncancerous renal proximal tubular epithelial (HK-2) cells and that RES will reduce DOX mediated changes in mitochondrial function. HK-2 cells were plated and grown for 48 hours (h). Cells were next preincubated for 1h with 0 (DMSO), 5 or 7.5 µM RES followed by a 24 h co-incubation with 0-5 µM DOX. RES did not alter cell growth or viability at the concentrations tested as indicated by comparable MTT values between DMSO and RES groups (p&gt;0.05). Cell viability was further assessed by cell count using Trypan blue exclusion. DOX produced a concentration dependent decline in viability within a 24 h exposure. Pretreatment for 1 h with RES was sufficient to reduce DOX loss of cell viability. Studies were initiated to investigate the cellular mechanism of RES attenuation of DOX cytotoxicity. Western blot of cells following 24 h exposure examined increased protein carbonylation as an indicator of oxidative stress. Initial studies were begun to examine the DOX effects on mitochondrial oxygen consumption using a Seahorse platform. In summary, RES did not diminish cell viability at the concentrations tested in our HK-2 cells. DOX diminished cell viability within 24 h relative to vehicle control. A 1 h pretreatment with RES reduced DOX cytotoxicity in HK-2 cells. Prevention of mitochondrial impairment and oxidative stress by DOX are potential mechanisms for RES protection in HK-2 cells.","abstract_has_math":false,"creators":["Getty, Morghan Schuyler"],"institution":null,"degree_name":"Biomedical Sciences","degree_level":"Thesis","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["Monica Valentovic","Gary Rankin","Travis Salisbury"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:57:03Z","subjects":["Chemicals and Drugs","Medical Cell Biology","Medical Sciences","Medical Toxicology","Medicine and Health Sciences","Oncology","Pharmacy and Pharmaceutical Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1137","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1137","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2140","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Monica Valentovic","Gary Rankin","Travis Salisbury"]},{"key":"dc:creator","label":"Author","values":["Getty, Morghan Schuyler"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-01-14T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2017-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Chemicals and Drugs","Medical Cell Biology","Medical Sciences","Medical Toxicology","Medicine and Health Sciences","Oncology","Pharmacy and Pharmaceutical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1137"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The cancer chemotherapeutic agent doxorubicin (DOX), Adriamycin, is part of the treatment regimen for breast, ovarian, small cell lung cancer and acute/chronic lymphoid leukemia. Adverse effects associated with DOX are cardiotoxicity and nephrotoxicity. Interventions are needed to reduce DOX nephrotoxicity. Resveratrol (RES) is a phytochemical contained in grapes, berries and nuts, which possesses antioxidant and anticancer properties. This study tested the hypothesis that RES will attenuate DOX renal cytotoxicity in human noncancerous renal proximal tubular epithelial (HK-2) cells and that RES will reduce DOX mediated changes in mitochondrial function. HK-2 cells were plated and grown for 48 hours (h). Cells were next preincubated for 1h with 0 (DMSO), 5 or 7.5 µM RES followed by a 24 h co-incubation with 0-5 µM DOX. RES did not alter cell growth or viability at the concentrations tested as indicated by comparable MTT values between DMSO and RES groups (p>0.05). Cell viability was further assessed by cell count using Trypan blue exclusion. DOX produced a concentration dependent decline in viability within a 24 h exposure. Pretreatment for 1 h with RES was sufficient to reduce DOX loss of cell viability. Studies were initiated to investigate the cellular mechanism of RES attenuation of DOX cytotoxicity. Western blot of cells following 24 h exposure examined increased protein carbonylation as an indicator of oxidative stress. Initial studies were begun to examine the DOX effects on mitochondrial oxygen consumption using a Seahorse platform. In summary, RES did not diminish cell viability at the concentrations tested in our HK-2 cells. DOX diminished cell viability within 24 h relative to vehicle control. A 1 h pretreatment with RES reduced DOX cytotoxicity in HK-2 cells. Prevention of mitochondrial impairment and oxidative stress by DOX are potential mechanisms for RES protection in HK-2 cells."]},{"key":"dc:title","label":"Title","values":["Doxorubicin Cytotoxicity in a Human Proximal Tubular Epithelial Cell Line was Attenuated by the Natural Product Resveratrol"]}]}],"canonical_facts":{"dc:contributor":["Monica Valentovic","Gary Rankin","Travis Salisbury"],"dc:creator":["Getty, Morghan Schuyler"],"dc:date.available":["2019-01-14T08:00:00Z"],"dc:date.created":["2017-01-01T08:00:00Z"],"dc:description.abstract":["The cancer chemotherapeutic agent doxorubicin (DOX), Adriamycin, is part of the treatment regimen for breast, ovarian, small cell lung cancer and acute/chronic lymphoid leukemia. Adverse effects associated with DOX are cardiotoxicity and nephrotoxicity. Interventions are needed to reduce DOX nephrotoxicity. Resveratrol (RES) is a phytochemical contained in grapes, berries and nuts, which possesses antioxidant and anticancer properties. This study tested the hypothesis that RES will attenuate DOX renal cytotoxicity in human noncancerous renal proximal tubular epithelial (HK-2) cells and that RES will reduce DOX mediated changes in mitochondrial function. HK-2 cells were plated and grown for 48 hours (h). Cells were next preincubated for 1h with 0 (DMSO), 5 or 7.5 µM RES followed by a 24 h co-incubation with 0-5 µM DOX. RES did not alter cell growth or viability at the concentrations tested as indicated by comparable MTT values between DMSO and RES groups (p>0.05). Cell viability was further assessed by cell count using Trypan blue exclusion. DOX produced a concentration dependent decline in viability within a 24 h exposure. Pretreatment for 1 h with RES was sufficient to reduce DOX loss of cell viability. Studies were initiated to investigate the cellular mechanism of RES attenuation of DOX cytotoxicity. Western blot of cells following 24 h exposure examined increased protein carbonylation as an indicator of oxidative stress. Initial studies were begun to examine the DOX effects on mitochondrial oxygen consumption using a Seahorse platform. In summary, RES did not diminish cell viability at the concentrations tested in our HK-2 cells. DOX diminished cell viability within 24 h relative to vehicle control. A 1 h pretreatment with RES reduced DOX cytotoxicity in HK-2 cells. Prevention of mitochondrial impairment and oxidative stress by DOX are potential mechanisms for RES protection in HK-2 cells."],"dc:identifier":["https://mds.marshall.edu/etd/1137"],"dc:subject":["Chemicals and Drugs","Medical Cell Biology","Medical Sciences","Medical Toxicology","Medicine and Health Sciences","Oncology","Pharmacy and Pharmaceutical Sciences"],"dc:title":["Doxorubicin Cytotoxicity in a Human Proximal Tubular Epithelial Cell Line was Attenuated by the Natural Product Resveratrol"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Biomedical Sciences"]},"updated_at":"2026-11-21T19:57:03Z"}